Spero Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 26, 2026

Go back to Spero Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 26, 2026
SmartPros Ltd. (NASDAQ: SPRO) Delayed: 2.15 -0.06 (2.71%)
Previous Close $2.21    52 Week High $3.85 
Open $2.16    52 Week Low $1.25 
Day High $2.23    P/E N/A 
Day Low $2.15    EPS $-0.28 
Volume 608,893